The research teams believes they can print parts and assemble an entire hearth within five years, but it could be years beyond that before its ready to be placed in a person, according to a Louisville Business First report.
The first patients to receive the “bioficial heart” — a blend of natural and artificial — would most likely be those with failing hearts who are not candidates for artificial hearts, including children whose chests are too small for an artificial heart.
The University of Louisville team has already printed human heart valves and small veins with cells, and they have also successfully tested the tiny blood vessels in mice and other small animals, according the report.
More Articles on 3-D Printing:
Physicians Turning to 3-D Printing to Develop Pediatric Devices
Intermountain Healthcare Launches Transformation Lab
First 3-D Printed Skull Successfully Implanted
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit